Commentary
Drug Development for Rare Diseases: Challenges and Regulatory Initiatives
Bax BE*
Reader in Rare Diseases, Cell Biology and Genetics Research Centre, St George's University of London, UK
- *Corresponding Author:
- Bridget E Bax
Reader in Rare Diseases, Molecular & Clinical Sciences Research Institute
Cell Biology and Genetics Research Centre, St George's University of London
Cranmer Terrace, London, SW17 0RE, UK
Tel: + 44-0-20-8266-6836
E-mail: bebax@sgul.ac.uk
Received date: May 10, 2017; Accepted date: May 11, 2017; Published date: May 12, 2017
Citation: Bridget E Bax (2017) Drug Development for Rare Diseases: Challenges and Regulatory Initiatives. Arch Sci 1:107. doi:10.4172/science.1000107
Copyright: © 2017 Bax BE. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
